<p>There are provided compounds of formula I and enantiomers and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control, amelioration or prevention of cancer.</p>
申请公布号
WO2012007409(A1)
申请公布日期
2012.01.19
申请号
WO2011EP61716
申请日期
2011.07.11
申请人
F. HOFFMANN-LA ROCHE AG;CHU, XIN-JIE;DING, QINGJIE;JIANG, NAN;LIU, JIN-JUN;ROSS, TINA MORGAN;ZHANG, ZHUMING
发明人
CHU, XIN-JIE;DING, QINGJIE;JIANG, NAN;LIU, JIN-JUN;ROSS, TINA MORGAN;ZHANG, ZHUMING